These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21162895)

  • 1. [Management of coronary atherosclerotic heart disease through an alliance of community and hospital].
    Zhong YG; Wang NF; Li H; Guo SZ; Zhou ZL; Tong GX; Lin J; Sheng GA; Wang YB; Xu P; Liu Y; Zou JW
    Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2675-8. PubMed ID: 21162895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Curative effects on standardized management of community patients with coronary heart disease complicated with chronic heart failure].
    Sun LN; Wang NF; Zhong YG; Li H; Guo SZ; Zhou ZL; Tong GX; Lin J; Sheng GA; Wang YB; Xu P; Liu Y; Zou JW
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(30):2341-4. PubMed ID: 24300198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate: a strong predictor of mortality in subjects with coronary artery disease.
    Palatini P
    Eur Heart J; 2005 May; 26(10):943-5. PubMed ID: 15774492
    [No Abstract]   [Full Text] [Related]  

  • 4. High mortality associated with precluded coronary artery bypass surgery caused by severe distal coronary artery disease.
    Rocha AS; Dassa NP; Pittella FJ; Barbosa ON; Brito JO; Tura B; Silva PR
    Circulation; 2005 Aug; 112(9 Suppl):I328-31. PubMed ID: 16159841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
    Yasuda K; Kasuga H; Aoyama T; Takahashi H; Toriyama T; Kawade Y; Iwashima S; Yamada S; Kawahara H; Maruyama S; Yuzawa Y; Ishii H; Murohara T; Matsuo S
    J Am Soc Nephrol; 2006 Aug; 17(8):2322-32. PubMed ID: 16837633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 24-h blood pressure measurement may predict mortality and cardiovascular events in hypertensive patients with coronary artery disease.
    Dzielińska Z; Prejbisz A; Makowiecka-Cieśla M; Januszewicz A; Tyczyński P; Demkow M; Zieliński T; Kadziela J; Florczak E; Ruzyłło W
    Blood Press Monit; 2009 Jun; 14(3):99-102. PubMed ID: 19417635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.
    Berger JS; Petersen JL; Brown DL
    Circ Cardiovasc Interv; 2009 Aug; 2(4):317-22. PubMed ID: 20031734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of heart failure as a consequence of perioperative myocardial injury after coronary artery bypass grafting.
    Steuer J; Granath F; de Faire U; Ekbom A; Ståhle E
    Heart; 2005 Jun; 91(6):754-8. PubMed ID: 15894769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the Heart.
    Anselmino M; Bartnik M; Malmberg K; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):28-36. PubMed ID: 17301624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate-to-severe ischemic mitral regurgitation and multivessel coronary artery disease: Impact of different treatment on survival and rehospitalization.
    Buja P; Tarantini G; Del Bianco F; Razzolini R; Bilato C; Ramondo A; Napodano M; Isabella G; Gerosa G; Iliceto S
    Int J Cardiol; 2006 Jul; 111(1):26-33. PubMed ID: 16061295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
    Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease.
    Joki N; Tanaka Y; Ishikawa H; Takahashi Y; Iwakura Y; Masuda H; Inishi Y; Hase H
    Am J Nephrol; 2009; 29(5):420-5. PubMed ID: 18997458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
    Diaz A; Bourassa MG; Guertin MC; Tardif JC
    Eur Heart J; 2005 May; 26(10):967-74. PubMed ID: 15774493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in outcomes after hospital discharge from coronary artery bypass grafting.
    Guru V; Fremes SE; Austin PC; Blackstone EH; Tu JV
    Circulation; 2006 Jan; 113(4):507-16. PubMed ID: 16449730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy over time of a short overall atherosclerosis management programme on the reduction of cardiovascular risk in patients after an acute coronary syndrome.
    Lafitte M; Pradeau V; Leroux L; Richeboeuf V; Tastet S; Boulon C; Paviot B; Bonnet J; Couffinhal T
    Arch Cardiovasc Dis; 2009 Jan; 102(1):51-8. PubMed ID: 19233109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in heart failure patients after major noncardiac surgery.
    Hernandez AF; Whellan DJ; Stroud S; Sun JL; O'Connor CM; Jollis JG
    J Am Coll Cardiol; 2004 Oct; 44(7):1446-53. PubMed ID: 15464326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progression.
    Gurbel PA; Kreutz RP; Bliden KP; DiChiara J; Tantry US
    Am Heart J; 2008 Jan; 155(1):56-61. PubMed ID: 18082490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.